Migraine Minute News Update
The Migraine Minute News Update is a weekly podcast that provides updates in migraine research and news, hosted by Molly O'Brien of the Association of Migraine Disorders. Each episode covers recent studies, treatments, and insights into migraine. The show is designed to inform patients and healthcare professionals about the latest developments. It is a concise and informative resource for anyone interested in migraine science.
Episodes
Clinical Trial Shows Promise for Pipeline Episodic & Chronic Migraine Preventive
Could a new migraine preventive treatment be on the horizon? A late-stage clinical trial shows promising new results for a migraine preventive in the pipeline. Molly O'Brien breaks it down in this Migraine Minute News Update. Link: https://bit.ly/3RFNARH FDA Drug Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125274s125lbl.pdf#page=30 Script: Research shows promising new result
Migraine Oral Preventives Vs. Galcanezumab
A real-world study suggests one migraine preventive may be more effective than some commonly prescribed oral treatments at three months. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read More: https://bit.ly/3TpJmhM Creative Commons: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script: New research published in Headache, the Journal of Head and Face Pain, shows th
Making OnabotulinumtoxinA Injections Less Painful
Ever wonder if there was a way to make OnabotulinumtoxinA injections less painful? New research suggests using this treatment before injections may help. Molly O'Brien explains in this Migraine Minute news update. Read the study: https://bit.ly/4wRHAFh Script: For many people with chronic migraine, onabotulinumtoxinA, also known as Botox, is an effective treatment, but it can come with injection
4th of July Migraine Triggers & Tips
Celebrating the Fourth of July with migraine is not easy. This festive holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O'Brien shares tips to help you enjoy the celebration while protecting your health. Check out our triggers webpage: https://bit.ly/4kFOZRf Script: While the Fourth of July can be a fun holiday to celebrate in the States, it can
Here's Why Fighting Migraine Stigma Matters
Why does fighting migraine stigma matter? That stigma we face may be more harmful than many people realize. Research shows increased stigma is linked with higher disease burden. Molly O'Brien breaks it all down in this Migraine Minute News Update. Read the study: https://bit.ly/4f8J6wv Script: June is Migraine and Headache Awareness Month, and you're likely going to hear a lot about fighting mig
Migraine & Tension Headache Linked With Body Pain
A new study shows body pain is more common and widespread in people with migraine or tension-type headache, and may be linked to a greater disease burden. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read more: https://bit.ly/41BVe10 Script: According to a study published in the Journal of Headache and Pain, body pain is more prevalent and widespread in people with ei
Migraine Days Drop in Kids Treated With Fremanezumab
According to a study in the New England Journal of Medicine, fremanezumab led to a greater reduction in migraine days per month than placebo in children and adolescents with episodic migraine. Molly O'Brien breaks down the study in this Migraine Minute News Update. Read the study: https://bit.ly/4csROT5 Script: In August of 2025, the FDA approved fremanezumab, sold under brand name Ajovy, for prev
Migraine + Fatigue: What New Research Reveals
Feeling drained with migraine? New research shows that more than half of people with migraine report fatigue, and it's tied to more frequent attacks and greater disability. Molly O'Brien breaks down the details in this Migraine Minute news update. Read More: https://bit.ly/4uNcspD Script: More than half of people living with migraine say they also struggle with fatigue. That's according to a new
Insurance Restrictions on Migraine Drugs Drive Higher ER Use
Insurance hurdles like prior authorization and step therapy prevent migraine patients from finding relief, but could payer blocking strategies lead to more ER and hospital visits? Molly O'Brien breaks it down the latest in this Migraine Minute news update. Read the study: https://bit.ly/40OlvJ0 The Migraine Policy Forum: https://www.linkedin.com/company/the-headache-migraine-policy-forum/ Scri
Study Shows Migraine More Common in People with Autism
As April is Autism Awareness Month, we're sharing new research on the relationship between migraine and autism. A study published in Headache shows people with autism are more likely to experience migraine or headache, and symptoms may be more severe. Molly O'Brien breaks it down in this Migraine Minute news update. Read the Study: https://bit.ly/3PyF3P3 Creative Commons: https://creativecommons.o
Sinus Infection or Migraine? New HEADS Registry Findings
Facial pain or pressure? It might not be a sinus infection. New findings from AMD's HEADS Registry suggest migraine may be behind these symptoms for some. Molly O'Brien breaks down the research in this Migraine Minute News Update. Read more: https://bit.ly/4aE9Dis Do you have sinus pain, dizziness, or ringing in the ears? The HEADS Registry is collecting patient experiences to improve care. Learn
This Treatment Cuts Migraine Days in Diverse Populations
Analysis of the COMPEL study shows that onabotulinumtoxinA (Botox) can help reduce migraine days, lower migraine-related disability, and improve quality of life in diverse populations of chronic migraine patients. Molly O'Brien breaks down the data in this Migraine Minute News Update. Read More: https://bit.ly/4trLxyK Researchers acknowledge that the term "race" doesn't accurately capture diverse
Migraine-Related Dizziness? Vestibular Rehab Shows Promise
Can vestibular rehab help vestibular migraine? A new review suggests that it may ease dizziness and improve daily functioning. Molly O'Brien breaks down the information in this Migraine Minute News Update. Read More: https://bit.ly/4aOHo18 Script: A new review published in Headache, The Journal of Head and Face Pain, looked at whether or not vestibular rehabilitation could be effective for vestib
Migraine Drug May Help Anxiety, Depression, and Sleep
Migraine preventive treatment benefits may go beyond fewer headache days. A new study links erenumab to improved symptoms of anxiety, depression, and poor sleep quality in some people with migraine. Molly O'Brien has the details in this Migraine Minute News Update. Read More: https://bit.ly/3LJl3r7 Script: A new study suggests that one migraine treatment may offer benefits beyond less headache da
Study Reveals Common, Early Migraine Warning Signs
In a study published in Headache, researchers identified 36 symptoms that can appear hours before a migraine attack. In this MM news update, Molly O'Brien highlights the most common symptoms, when they occur, and how recognizing these early signs can help people better treat their migraine attacks. Read more: https://bit.ly/4ozrewr Transcript: A new study published in Headache is among the first t
What the Migraine Community Knows About Migraine Progression
Our recent survey shows some people aren't aware migraine can progress—and many fear their attacks can get worse. Molly O'Brien breaks down the survey results in this MM news update. Do you worry about pain and symptoms getting worse? Let us know in the comments. Learn more: https://www.migrainedisorders.org/migraine-disorders/migraine-treatments/ Transcript: Did you know that migraine can be a pr
Update on Migraine Treatment During Pregnancy
Treating migraine in pregnancy can be challenging since many drugs carry risks. The good news is that the FDA updated precautions on a drug-free wearable device. Molly O'Brien has the story in this Migraine Minute News Update. Read More: http://bit.ly/4mMtfo1 Script: The FDA recently updated its precautionary language on the Nerivio neuromodulation device… removing the note that it has not been s
Study Says Cannabis Shows Promise for Migraine Relief
First-of-its-kind study: A new study suggests that a combination of THC + CBD works better than placebo, THC alone, or CBD alone for reducing migraine pain and symptoms. Molly O'Brien breaks it down in this Migraine Minute News Update. Read More: https://bit.ly/4qvpuWo Script: For the first time, researchers tested cannabis in a placebo-controlled trial for migraine… and results suggest it cou
Tried Multiple Migraine Treatments Without Relief? Atogepant May Help
A new real-world study shows atogepant (sold under brand name Qulipta) may quickly reduce migraine days—even for those who haven't responded to other treatments. Molly O'Brien has more in this Migraine Minute News Update! Read more: http://bit.ly/3UcEuJN CC License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Script: The GIANT study, published inThe Journal of Headache and Pain, offers re
Diabetes Drug May Cut Migraine Days in Half
Can diabetes and weight loss drugs help with migraine relief? A new study suggests GLP-1 medications may significantly reduce migraine days. @ Molly O'Brien has more in this Migraine Minute News Update. Read More: http://bit.ly/4kGN4eO Image and license to use: Headache. 2025; 00: 1-8. http://bit.ly/47imNQO Script: GLP-1s….a drug class widely used for diabetes and weight loss treatment, may al
Major Study Shows Triptans Top Other Oral Acute Meds
A major study found that oral triptans work better for the acute treatment of migraine, than newer drugs. Molly O'Brien breaks it all down in this Migraine Minute News Update. Read more: https://bit.ly/3Wu6ZnP Images and License to use: BMJ 2024;386:e080107http://bit.ly/4ljgU9x Script: A major international study published in the British Medical Journal found triptans to be the most effective acu
Psychedelic Use Linked to Fewer Frequent Headaches
A study in the Journal of Psychopharmacology found a surprising connection between psychedelic use and frequent bad headaches. Could psilocybin play a role in headache treatment? Molly O'Brien explains in this Migraine Minute News Update. Read more: http://bit.ly/40k21Mu Script: A new study in the Journal of Psychopharmacology shows that people who've used psychedelics like LSD or psilocybin ma
How Might Stress Trigger Migraine Pain?
Scientists are learning how stress may trigger a series of brain responses that could be linked to migraine, at least in mice. Molly O'Brien has more in this Migraine Minute News Update. Source: PACAP38/mast-cell-specific receptor axis mediates repetitive stress-induced headache in mice Script: A study published in the Journal of Headache and Pain explains how stress can lead to migraine pain. R
FDA Approves Two New DHE Migraine Treatments for Fast Relief
Two innovative DHE-based migraine treatments just earned FDA approval—offering some Americans new options for managing attacks. Molly O'Brien has details in this #MigraineMinute News Update. Read More: https://bit.ly/4kgmXMt and https://bit.ly/3SYet0c *DHE is not safe for the management of hemiplegic migraine, migraine with brainstem aura, in people with certain comorbidities, or in those who take
Navigating the 4th of July with Migraine: Triggers & Tips
Celebrating the Fourth of July with migraine is not easy. The holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O'Brien shares tips to help you enjoy the celebration while protecting your health. Check out our updated triggers webpage: https://bit.ly/4kFOZRf Reference: https://pubmed.ncbi.nlm.nih.gov/19329386/ Script: While the Fourth of July can b
Does PACAP 38 Work Differently Than CGRP?
New research shows CGRP monoclonal antibody treatment may not prevent migraine attacks triggered by the neuropeptide PACAP-38. This study suggests PACAP-38 may act through a different pathway and could become a future preventive option for people who don't respond to CGRP-based treatments. Molly O'Brien explains in this Migraine Minute News Update. Read More: https://bit.ly/4ivy3LG Images courtes
Can Erenumab Treat Medication Overuse Headache?
A study published in JAMA Neurology shows that monthly erenumab injections may help treat medication overuse headache (MOH) in people with chronic migraine. While the 140 mg dose was effective for treating MOH, the 70 mg dose did not show a meaningful difference compared to placebo. Molly O'Brien explains in this Migraine Minute News Update. Read More: https://bit.ly/4jCusxk Image Courtesy: JAMA N
Predicting if a Preventive Migraine Treatment Will Work
Most people with migraine go through trial and error to find a preventive treatment that works. But researchers at the Mayo Clinic may have found a way to change that. Using AI, they developed a tool to predict how someone might respond to certain migraine medications—particularly CGRP monoclonal antibodies. Molly O'Brien has more in this Migraine Minute News Update. Read More: https://bit.ly/40uK
Can This Preventive Drug Bring Immediate Migraine Relief?
Rapid relief from a preventive migraine treatment? A study published in Neurology shows that one oral gepant medication may start working right away to prevent migraine attacks. Molly O'Brien fills you in, in this Migraine Minute News Update. Read more: https://bit.ly/3Wvb1fU
FDA Approves Axsome's New Migraine Drug Symbravo®
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O'Brien has the details and when it becomes available in this Migraine Minute News update. Learn More: https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-fda-approval-symbravor-meloxicam
Can CGRP Blocking Drugs Help Endometriosis?
Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O'Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month. Read More: https://bit.ly/4jp0cG2 AMD Comorbidities Library: https://bit.ly/3CIrLtd
Cluster Headache Often Coexists with Fibromyalgia & Migraine
Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O'Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions. Learn More: https://bit.ly/42pSNQS
Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O'Brien has the details in this Migraine Minute News Update. Read More: https://bit.ly/3BY2J9d
FDA Clears Nerivio Device for Children 8+
Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O'Brien explains the FDA clearance of Theranica's Nerivio device for acute and preventive migraine treatment in kids. Read more: https://bit.ly/4fRXRk5
MERTK as a Potential Novel Target for Cluster Headache
Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache. In this Migraine Minute News Update Molly O'Brien breaks down what it means for people living with Cluster. Read More: https://bit.ly/3ZXzTQ0
No Link Between Migraine and Risk of Parkinson's Disease
Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson's disease. Molly O'Brien explains in this Migraine Minute News Update. Want to know more about Migraine and Parkinson's disease? Check out this article in AMD's Comorbidities library: https://bit.ly/3XZSaJB
New Treatment Targets PACAP for Migraine Prevention
A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo. In this Migraine Minute News Update Molly O'Brien explains. Read More: https://bit.ly/3XXXNrR
NINDS Funds Research on the Link Between Headache Disorders & the Circadian Clock
The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O'Brien has details in this Migraine Minute News Update. Read more: bit.ly/3BsNwfT
Can CGRP blockers impact blood pressure in people over 60?
A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O'Brien explains the findings. Read More: bit.ly/3zpcYSB
Are CGRP mAbs Cost Effective?
A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more: http://bit.ly/3S1KS5Y Image courtesy: DOI 10.1186/s10194-024-01727-0
Atogepant vs. Rimegepant. New study looks at indirect comparison
A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: bit.ly/4cwJQar Image courtesy: Sage Journals. Cephalalgia doi:10.1177/03331024241235156
Is there a link between photophobia and poor sleep quality?
Light sensitivity and poor sleep quality in people with migraine, could the two be related? In a study published in the Journal of Headache and Pain, researchers looked at the impact photophobia may have on sleep quality in people with migraine. Molly O'Brien breaks it down in this Migraine Minute News Update. Learn more: bit.ly/4cIJMUD
Can a caffeine habit impact episodic migraine?
Caffeine habit? A new study looks at the link between episodic migraine and regular caffeine intake. Molly O'Brien will fill you in, in this latest Migraine Minute News Update. Learn more about the study at bit.ly/4bzLyXu
FDA Clears a New TENS Device for Migraine Prevention
The US FDA clears another wearable drug-free migraine treatment device. In this Migraine Minute News Update, Molly O'Brien will tell you all about a new TENS device available for people with episodic migraine. Read more: https://bit.ly/4aEZFe9
Do CGRP Monoclonal Antibodies wear off at the end of the month?
Many people with chronic migraine worry that their monthly preventive medication won't work as well at the end of the month as it did at the beginning. New research shows that two injectable CGRP monoclonal antibodies do not wear off at the end of the month. Molly O'Brien has the details in this #MigraineMinute News Update. Read more: bit.ly/3w95WQn
Can This Gepant be an Effective Preventive Treatment Option for Tough to Treat Episodic Migraine?
A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O'Brien explains in this Migraine Minute News Update. Read the study here: https://bit.ly/3w3ZM45
Comparing Anti-CGRP monoclonal antibodies to OnabotulinumtoxinA for chronic migraine
A new study looks at real-word effectiveness of Anti-CGRP monoclonal antibodies & OnabotulinumtoxinA for chronic migraine. Molly O'Brien will share the study findings in this Migraine Minute News update. Read the study: https://bit.ly/4d1mPx1 *The graphic used in this content is courtesy of Grazzi, L., Giossi, R., Montisano, D.A. et al. Real-world effectiveness of Anti-CGRP monoclonal antibodies
Can blood flow changes in the eyes explain visual migraine symptoms?
Researchers at the University of California Los Angeles found changes in blood flow in the retina might explain why some people have visual migraine symptoms. Molly O'Brien has the details in this Migraine Minute News update. Learn more: https://bit.ly/3xou7uw , https://bit.ly/4aErYZN
Exclusive! A First Look at Survey Results From the HEADS Registry
AMD is thrilled to share what we've learned so far from our HEADS Registry! Molly O'Brien goes over the exclusive new data in this Migraine Minute News Update. The HEADS Registry serves as a crucial resource for researchers and clinicians. It's not too late to share your experience, by doing so, you can help pave the way for more effective therapies, enhanced and personalized patient care, and i
Migraine Minute News Update: One CGRP MAB Drug May Reduce Migraine Attacks in Adults with Obesity
Obesity is often connected with an increase in migraine frequency, severity and disability. In this Migraine Minute News Update, Molly O'Brien gives details on what we're learning about one MAB drug and its effectiveness in people with migraine and comorbid obesity. Read more here: https://bit.ly/3ONRu6m
Migraine Minute News Update: Is there a link between migraine stigma and quality of life?
New results from the OVERCOME study, published in Neurology, Found that just over 31 percent of people living with migraine often or very often feel stigmatized. Molly O'Brien will fill you in on the details in this Migraine Minute News Update.
One Drug-Free Migraine Treatment Becomes First To Get Commercial Insurance Coverage
Nerivio becomes the first drug-free Migraine Treatment to Receive Commercial Insurance Coverage in the US. Molly O'Brien explains in this Migraine Minute News Update. Read more here: https://bit.ly/3T6lKvL
What Do We Know About Migraine and ADHD Symptoms?
We know Migraine and ADHD are comorbid, but there is still a lot left to learn about how they are connected. @Molly O'Brien will fill you in on new research that explores ADHD symptoms in people with migraine. Sources: https://bit.ly/3vNm6hT
Does Second Hand Cigarette Smoke Impact Migraine?
Second hand smoke can often be a trigger for people with migraine, but is there a connection between how much exposure someone has to second hand smoke and migraine disease? Molly O'Brien talks about the latest research in this Migraine Minute News Update. Read the full story: https://bit.ly/3vE2MDD
Migraine Minute News Update: These 3 Drugs May Be More Effective Than Ibuprofen for Migraine Treatment
Feel a migraine attack coming on? New research shows these three types of medications may be more effective than ibuprofen for many people. Molly O'Brien will share details in this Migraine Minute News Update. Read more here: https://bit.ly/47HEwh9
Migraine Minute News Update: Taking this drug during the migraine prodrome may help prevent severe headache.
New research shows taking one type of gepant medication during the prodrome phase may reduce the risk of a severe headache. Molly O'Brien will fill you in, in this Migraine Minute News Update. Read the study here: https://bit.ly/3GLKEtT
Migraine Minute News Update: Looking for a New Year's Resolution? Try mindfulness for migraine.
Are you looking for new ways to manage migraine in the new year? Practicing mindfulness may help. Molly O'Brien explains in this Migraine Minute News Update. More info: https://bit.ly/3RRdVd1
Migraine Minute News Update: Fifth Harmony's Ally Brooke Hernandez opens up about migraine
Singer and actress Ally Brooke Hernandez rose to international fame as a member of the all-female singing group Fifth Harmony. In an interview with People en Espanol, Hernandez spoke out about how migraine has impacted her life and career. Molly O'Brien will fill you in on this Migraine Minute News Update. Read the full story: https://bit.ly/3FG2Q7s
Migraine Minute News Update 11.10.23: Veterans are disproportionately impacted by headache disorders
As we honor and celebrate those who have and continue to serve our country on Veterans Day, the Association of Migraine Disorders wants to raise awareness about how headache disorders affect those who serve. To our brave service members, thank you. Learn more about how headache impacts Veterans and services the VA offers: https://bit.ly/45Y94dC https://bit.ly/3FG37r0
Migraine Minute News Update 10.27.23
A new survey shows Nerivio may be a safe treatment option during pregnancy. Molly O'Brien with the Association of Migraine Disorders will fill you in with the latest Migraine Minute News Update. For more information and full details about the study check out this link: https://bit.ly/3EQ2lHE
10.13.23 Migraine Minute News Update: HEADS Registry
The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a new research initiative launched by the Association of Migraine Disorders. The HEADS Registry captures information about people who have sinus, vestibular, and auditory symptoms. In this Migraine Minute News Update Molly O'Brien will explain how your experiences can help advance research. Get more information and a link to sign up
Migraine Minute News Update 9.29.23: Botulinum Toxin for Pediatric Migraine
New research shows that botulinum toxin treatments for migraine in adolescents may be more effective than past studies state. Molly O'Brien will fill you in on the latest in this week's Migraine Minute News Update. For more information: https://www.sciencedirect.com/science/article/abs/pii/S0887899423002138
Migraine Minute News Update 9.15.23: Could an implanted device help treat migraine and cluster headaches?
A Dutch medical device company announces its first clinical trial of an implanted neuromodulation device to help treat migraine and cluster headache. MollyO'Brien has the latest in this Migraine Minute News Update.
Migraine Minute 9.1.23: More than $2 million dollars will fund new migraine research
The American Heart Association has awarded 2.1 million dollars to research the link between migraine, stroke, and heart disease. Molly O'Brien will fill you in with the latest Migraine Minute News Update. For more information and the full story check out this link: https://bit.ly/45wOqSx
Migraine Minute News Update - August 18, 2023
Caffeine! Researchers continue to learn more about how caffeine can impact people with migraine. Molly O'Brien will fill you in with the latest Migraine Minute News Update. Follow @migrainedisorders to catch these updates. For more information and full details about the study check out this link: https://go.nature.com/44jRO28
Migraine Minute News Update - August 4, 2023
In a recent interview with Insider, #Olympic #gymnastics champion #AlyRaisman opens up about her life with #migraine and why pushing through the pain wasn't healthy. Molly O'Brien will fill you in on the latest in this week's Migraine Minute News Update. Follow @migrainedisorders. Read the full story: https://bit.ly/3NSGcxC
Migraine Minute News Update - July 21, 2023
Do you have more migraine attacks in the summer? Changes in weather, barometric pressure, and upended schedules could be part of the reason why. Molly O'Brien will fill you in with the latest Migraine Minute News Update. Follow @migrainedisorders to catch these updates. For more information and the full story check out this link: https://mayocl.in/442HfAZ
Migraine Minute News Update - July 7, 2023
A new study published in the Journal of Medical Economics shows that using Nerivio can lead to big cost savings when used as a preventative treatment. For more information and full details about the study read the article using the link: https://bit.ly/42Y8j3
Migraine Minute News Update - June 23, 2023
A recent article looks at the possible benefits of using venlafaxine to help with vestibular migraine. The article states that much like other drugs, venlafaxine did not reduce the function (restrictions, difficulties, avoidances) or physical aspects of VM (which activities exacerbate the problem). It did, although help with the emotional aspects of VM–like feelings of frustration, anger, embarras
Migraine Minute News Update - June 9, 2023
It's commonly known that migraine and endometriosis are comorbid– but information on the differences in symptoms and severity of endometriosis in people with migraine is still lacking. Researchers are learning more about how the two are linked. Molly O'Brien will catch you up in the latest Migraine Minute News Update. Follow @migrainedisorders. More Info: https://bit.ly/3Mx9L7j
Migraine Minute News Update - May 26, 2023
What do we know about the safety of onabotulinumtoxinA injections for migraine during pregnancy? Molly O'Brien will fill you in on the latest in this week's Migraine Minute News Update. Follow @migrainedisorders. More info: https://bit.ly/3Md2fwY
Migraine Minute News Update - May 19, 2023
Do you usually experience migraine attacks on the left or right side of your head? Scientists found differences in migraine on each side! Molly O'Brien will fill you in with the latest Migraine Minute News Update. Follow @migrainedisorders to catch every update. For more information and full details about the study check out this link: https://bit.ly/3IivcXj
Migraine Minute News Update - May 9, 2023
Do you get migraine or cluster attacks around the same time of day? New research shows that isn't a coincidence! Molly O'Brien will fill you in on the latest migraine news in this week's Migraine Minute. Follow @migrainedisorders to catch these updates. More info: https://www.uth.edu/news/story/cluster-headache-migraine-strongly-associated-with-circadian-system-according-to-published-research
Migraine Minute News Update - May 5, 2023
The FDA approves a new prevention therapy for chronic migraine. @Molly O'Brien will fill you in on the latest migraine news in this week's Migraine Minute. Follow @migrainedisorders to catch these updates. More info: https://news.abbvie.com/news/press-releases/us-fda-approves-qulipta-atogepant-for-adults-with-chronic-migraine.htm
Migraine Minute News Update - April 17, 2023
Do you have trouble talking or focusing during a migraine attack? You're not alone. Molly O'Brien will get you caught up on the latest migraine news in this Migraine Minute News Update. Follow @migrainedisorders. More info: https://bit.ly/3zIaHi9 https://bit.ly/3GUoVk3
Migraine Minute News Update - March 31, 2023
What do we know about smoking cigarettes and migraine? Molly O'Brien will get you caught up on the latest migraine news in this Migraine Minute News Update. Follow @migrainedisorders. More info: https://bit.ly/3zti4Kh https://bit.ly/40lL8yR https://bit.ly/3FWqCN2
Migraine Minute News Update - March 20, 2023
*Alert* New acute and preventative #migraine treatment options! Molly O'Brien will get you caught up in this Migraine Minute News Update. Follow @migrainedisorders for the latest in migraine. More info: https://bit.ly/3JCjx6M https://bit.ly/3YPGLKZ https://bit.ly/3TfGeAQ MigraineDisorders.org
Migraine Minute News Update - March 3, 2023
What's the relationship between migraine and anxiety? Molly O'Brien will fill you in on that and the latest on a migraine drug in the pipeline. More info: https://bit.ly/3xXLoHS https://www.migrainedisorders.org/the-link-between-migraine-and-anxiety/ www.MigraineDisorders.org
Migraine Minute News Update - February 17, 2023
Can history of migraine be an indicator of pregnancy complications? Molly O'Brien will fill you in on the latest migraine news in this Migraine Minute News Update. More info: https://bit.ly/3HD6L5K https://bit.ly/3YvdwNC https://go.nature.com/3YBMbcY https://bit.ly/3xczxVO https://www.migrainedisorders.org/education/patient-resources/videos/ MigraineDisorders.org
Migraine Minute News Update - February 6, 2023
Are nerve blocks a good migraine treatment option? What's the connection between ADHD and migraine? Molly O'Brien will fill you in on the latest migraine news in this Migraine Minute News Update. Catch episodes by following @migrainedisorders. More info: https://bit.ly/3iWd9wN https://bit.ly/3WVCCFm https://www.migrainedisorders.org/migraine-and-adhd/ MigraineDisorders.org
Recommended
Bad Friends
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Bread and Banter Podcast
The Church of What's Happening Now: The New Testament
Deadline: White House
English Vocabulary Help
این نقطه
Solved Murders - True Crime Stories
紐約鳥｜New York Aperture
Doctor Zhivago Slow Read
Apple News In Conversation
The Young and Called Podcast .
